Demlová R - Search Results

1

[KRAS mutation testing in therapeutic algorithm for treatment of metastatic colorectal carcinoma].

Dubská L, Vyskocilová M, Nenutil R, Valík D, Knoflícková D, Fabian P, Kocáková I, Demlová R, Beránek M, Drastíková M, Vosmiková H, Bóday A, Horká K, Símová J, Drábek J, Ehrmann J, Hajdúch M, Matejcková M, Síma R, Tvrdík D, Povýsil C, Ryska A. Dubská L, et al. Among authors: demlova r. Cas Lek Cesk. 2011;150(6):321-6. Cas Lek Cesk. 2011. PMID: 21751504 Review. Czech.

2

[Vitamin D: Its physiology, pathophysiology and significance in etiopathogenesis of malignant diseases].

Drábová K, Bienertová-Vašků J, Lokaj P, Dubská L, Obermannová R, Greplová K, Demlová R, Valík D, Stěrba J. Drábová K, et al. Among authors: demlova r. Cas Lek Cesk. 2013;152(1):20-30. Cas Lek Cesk. 2013. PMID: 23448673 Review. Czech.

3

Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer.

Vyzula R, Kocáková I, Demlová R, Kiss I, Dusek L, Jarkovský J. Vyzula R, et al. Among authors: demlova r. Neoplasma. 2006;53(2):119-27. Neoplasma. 2006. PMID: 16575467 Clinical Trial.

4

The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors.

Demlova R, Valík D, Obermannova R, ZdraŽilová-Dubská L. Demlova R, et al. Physiol Res. 2016 Dec 21;65(Suppl 4):S455-S462. doi: 10.33549/physiolres.933525. Physiol Res. 2016. PMID: 28006927 Free article. Review.

5

Myeloid-derived suppressor cells (MDSCs) in patients with solid tumors: considerations for granulocyte colony-stimulating factor treatment.

Pilatova K, Bencsikova B, Demlova R, Valik D, Zdrazilova-Dubska L. Pilatova K, et al. Among authors: demlova r. Cancer Immunol Immunother. 2018 Dec;67(12):1919-1929. doi: 10.1007/s00262-018-2166-4. Epub 2018 May 10. Cancer Immunol Immunother. 2018. PMID: 29748897 Free PMC article. Review.

6

[New radiopharmaceuticals and positron-emission tomography applications at the Masaryk Memorial Cancer Institute in Brno].

Adam J, Andres P, Bolcák K, Cermáková M, Demlová R, Dubská L, Sedlácková S, Valík D. Adam J, et al. Among authors: demlova r. Klin Onkol. 2009;22(3):94-7. Klin Onkol. 2009. PMID: 19708542 Czech.

7

Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folate.

Valik D, Sterba J, Bajciova V, Demlova R. Valik D, et al. Among authors: demlova r. Oncology. 2005;69(3):269-72. doi: 10.1159/000088334. Epub 2005 Sep 15. Oncology. 2005. PMID: 16166815

8

Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.

Sterba J, Dusek L, Demlova R, Valik D. Sterba J, et al. Among authors: demlova r. Clin Chem. 2006 Apr;52(4):692-700. doi: 10.1373/clinchem.2005.061150. Epub 2006 Feb 2. Clin Chem. 2006. PMID: 16455868

9

NKT-like cells are expanded in solid tumour patients.

Zdrazilova-Dubska L, Valik D, Budinska E, Frgala T, Bacikova L, Demlova R. Zdrazilova-Dubska L, et al. Among authors: demlova r. Klin Onkol. 2012;25 Suppl 2:2S21-5. Klin Onkol. 2012. PMID: 23581012

10

Host-dependent variables: The missing link to personalized medicine.

Demlova R, Zdrazilova-Dubska L, Sterba J, Stanta G, Valik D. Demlova R, et al. Eur J Surg Oncol. 2018 Sep;44(9):1289-1294. doi: 10.1016/j.ejso.2018.04.014. Epub 2018 Apr 26. Eur J Surg Oncol. 2018. PMID: 29735363 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters